{
    "body": "Is TALEN being used on stem cells?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24305178", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24206569", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25245091", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25408877", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24155235", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24319658", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24691488", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25434822", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26052525", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23246482", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24996167", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23928856", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23666012", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25414332", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23921522", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23945944", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21738127", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22749015"
    ], 
    "triples": [
        {
            "p": "http://www.w3.org/2004/02/skos/core#notation", 
            "s": "http://linkedlifedata.com/resource/umls/label/A0036575", 
            "o": "D013234"
        }, 
        {
            "p": "http://www.w3.org/2004/02/skos/core#notation", 
            "s": "http://linkedlifedata.com/resource/umls/label/A0119455", 
            "o": "D013234"
        }, 
        {
            "p": "http://www.w3.org/2004/02/skos/core#notation", 
            "s": "http://linkedlifedata.com/resource/umls/label/A0036467", 
            "o": "D013234"
        }, 
        {
            "p": "http://www.w3.org/2004/02/skos/core#notation", 
            "s": "http://linkedlifedata.com/resource/umls/label/A0119446", 
            "o": "D013234"
        }
    ], 
    "ideal_answer": [
        "Yes, TALEN is being used on stem cells for genome editing."
    ], 
    "exact_answer": "yes", 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013234", 
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002477"
    ], 
    "type": "yesno", 
    "id": "56f555b609dd18d46b000007", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 137, 
            "text": "Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25434822", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 119, 
            "offsetInEndSection": 323, 
            "text": "Genetic correction of patient-derived induced pluripotent stem cells (iPSCs) by TALENs or CRISPR-Cas9 holds promise for DMD gene therapy; however, the safety of such nuclease treatment must be determined.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25434822", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 124, 
            "offsetInEndSection": 392, 
            "text": "We generated helper-dependent, capsid-modified adenovirus (HD-Ad5/35) vectors for zinc-finger nuclease (ZFN)- or transcription activator-like effector nuclease (TALEN)-mediated genome editing in human CD34+ hematopoietic stem cells (HSCs) from mobilized adult donors. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/26052525", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 344, 
            "offsetInEndSection": 564, 
            "text": "We used transcription activator-like effector nuclease (TALEN)-mediated gene editing in mouse embryonic stem cells (mESCs) to produce mice with targeted gene disruptions and insertions in two Y-linked genes--Sry and Uty.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23666012", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 145, 
            "text": "Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free \u03b2-thalassemia induced pluripotent stem cells.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24155235", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 82, 
            "text": "A TALEN genome-editing system for generating human stem cell-based disease models.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23246482", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 142, 
            "text": "Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24996167", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 623, 
            "offsetInEndSection": 820, 
            "text": "Using CRISPR-Cas9 and TALEN targeted human pluripotent stem cell clones, we performed whole-genome sequencing at high coverage in order to assess the degree of mutagenesis across the entire genome.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24996167", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 118, 
            "text": "A modified TALEN-based system for robust generation of knock-out human pluripotent stem cell lines and disease models.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24206569", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 464, 
            "offsetInEndSection": 558, 
            "text": "In this study, we utilized a cell-penetrating peptide-based system for ZFN and TALEN delivery.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25408877", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 470, 
            "offsetInEndSection": 650, 
            "text": "At all loci tested we obtained human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21738127", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 474, 
            "offsetInEndSection": 753, 
            "text": "We report here the use of TALENs to rapidly and efficiently generate mutant alleles of 15 genes in cultured somatic cells or human pluripotent stem cells, the latter for which we differentiated both the targeted lines and isogenic control lines into various metabolic cell types.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23246482", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 170, 
            "text": "Zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) have been successfully used to knock out endogenous genes in stem cell research.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25408877", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 432, 
            "offsetInEndSection": 682, 
            "text": "Here we report different methods to efficiently perform TALEN-mediated gene integration and inactivation in different mammalian cell systems including induced pluripotent stem cells and delineate experimental examples associated with these approaches", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25047178", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 954, 
            "offsetInEndSection": 1163, 
            "text": "Together, our results demonstrate that TALE-based transcriptional repressor and TALENs are two promising approaches for loss-of-function studies of microRNA clusters in somatic cells and pluripotent stem cells", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24319658", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 196, 
            "offsetInEndSection": 474, 
            "text": "We report here the use of TALENs to rapidly and efficiently generate mutant alleles of 15 genes in cultured somatic cells or human pluripotent stem cells, the latter for which we differentiated both the targeted lines and isogenic control lines into various metabolic cell types", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23246482", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 106, 
            "text": "TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25245091", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 154, 
            "text": "Baculoviral transduction facilitates TALEN-mediated targeted transgene integration and Cre/LoxP cassette exchange in human-induced pluripotent stem cells.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23945944", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 125, 
            "offsetInEndSection": 346, 
            "text": "We used transcription activator-like effector nuclease (TALEN)-mediated gene editing in mouse embryonic stem cells (mESCs) to produce mice with targeted gene disruptions and insertions in two Y-linked genes--Sry and Uty. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23666012", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 428, 
            "offsetInEndSection": 626, 
            "text": "Using CRISPR-Cas9 and TALEN targeted human pluripotent stem cell clones, we performed whole-genome sequencing at high coverage in order to assess the degree of mutagenesis across the entire genome. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24996167", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 965, 
            "offsetInEndSection": 1246, 
            "text": "A 5% modification rate was observed in human induced pluripotent stem cells (hiPSCs) treated with TAT-TALEN as measured by the Surveyor assay.  TAT-TALEN protein-mediated gene disruption was applicable in hiPSCs and represents a promising technique for gene knockout in stem cells.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25408877", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 186, 
            "offsetInEndSection": 474, 
            "text": "Here we engineered transcription activator-like effector nucleases (TALENs) for five distinct genomic loci. At all loci tested we obtained human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21738127", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 125, 
            "text": "Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23928856", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 294, 
            "offsetInEndSection": 698, 
            "text": "At all loci tested we obtained human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location. Our data suggest that TALENs employing the specific architectures described here mediate site-specific genome modification in human pluripotent cells with similar efficiency and precision as do zinc-finger nucleases (ZFNs).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21738127", 
            "endSection": "abstract"
        }
    ]
}